Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    Open Studies | "Haemophilus Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Haemophilus Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants
Conditions: Diphtheria;   Acellular Pertussis;   Haemophilus Influenzae Type b;   Tetanus;   Poliomyelitis
Intervention: Biological: Infanrix™ -IPV/Hib
2 Recruiting A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix® -IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia
Conditions: Haemophilus Influenzae Type B Vaccines;   Diphtheria;   Hepatitis B;   Tetanus;   Pertussis
Intervention: Biological: Infanrix® -IPV/Hib
3 Recruiting Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine,Freeze-dried
Condition: Haemophilus Influenzae Type b Infections
Interventions: Biological: Minhai-HIB;   Biological: Act-HIB®
4 Recruiting Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks
Condition: Safety, Pentavalent Vaccine
Intervention: Biological: ComBe Five (Liquid)
5 Recruiting Phase 3 Study of BK1310 in Healthy Infants
Condition: Immunization; Infection
Interventions: Biological: DPT-IPV-Hib-High (Combined Vaccine);   Biological: DPT-IPV-Hib-Low (Combined Vaccine);   Biological: Hib vaccine;   Biological: DPT-IPV

Study has passed its completion date and status has not been verified in more than two years.